PDE4A and major depressive disorder: The radioligand [11C]rolipram, a nonselective PDE4 antagonist, was used to show reduced cAMP activity in MDD compared to controls, and an upregulation after selective serotonin reuptake inhibitor (SSRI) treatment [19].